Sabirin, Samira .

HRN: 21-89-09  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/12/2022
CEFUROXIME 750MG (VIAL)
09/12/2022
09/18/2022
IV
500mg
Q8
UTI
Waiting Final Action 
09/12/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
09/12/2022
09/19/2022
PO
7.5ml
Q8hours
Amoebiasis
Waiting Final Action 
09/14/2022
CEFTRIAXONE 1G (VIAL)
09/14/2022
09/20/2022
IV
2g
OD
Typhoid Fever
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: